These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vagal release of vasoactive intestinal peptide can promote vagotonic tachycardia in the isolated innervated rat heart. Shvilkin A; Danilo P; Chevalier P; Chang F; Cohen IS; Rosen MR Cardiovasc Res; 1994 Dec; 28(12):1769-73. PubMed ID: 7867028 [TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs. Rigel DF; Lathrop DA Circ Res; 1990 Dec; 67(6):1323-33. PubMed ID: 2245498 [TBL] [Abstract][Full Text] [Related]
7. Beneficial influence of vasoactive intestinal peptide on ventriculovascular coupling in closed-chest dogs. Colston JT; Freeman GL Am J Physiol; 1992 Oct; 263(4 Pt 2):H1300-5. PubMed ID: 1415777 [TBL] [Abstract][Full Text] [Related]
8. Effects of vasoactive intestinal polypeptide on heart rate in relation to vagal cardioacceleration in conscious dogs. Roossien A; Brunsting JR; Nijmeijer A; Zaagsma J; Zijlstra WG Cardiovasc Res; 1997 Feb; 33(2):392-9. PubMed ID: 9074704 [TBL] [Abstract][Full Text] [Related]
9. Vagal stimulation during muscarinic and beta-adrenergic blockade increases atrial contractility and heart rate. Henning RJ J Auton Nerv Syst; 1992 Sep; 40(2):121-9. PubMed ID: 1464693 [TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance. Cheng CP; Noda T; Nordlander M; Ohno M; Little WC J Pharmacol Exp Ther; 1994 Mar; 268(3):1232-41. PubMed ID: 8138936 [TBL] [Abstract][Full Text] [Related]
11. The effect of vagal stimulation on left ventricular systolic and diastolic performance. Xenopoulos NP; Applegate RJ Am J Physiol; 1994 Jun; 266(6 Pt 2):H2167-73. PubMed ID: 8023978 [TBL] [Abstract][Full Text] [Related]
12. Vagal-induced tachycardia: release of vasoactive intestinal peptide and peptide HI. Anderson FL; Kralios AC; Cluff N; Hanson GR Am J Physiol; 1994 Nov; 267(5 Pt 2):H2019-24. PubMed ID: 7977833 [TBL] [Abstract][Full Text] [Related]
13. Vagal stimulation attenuates sympathetic enhancement of left ventricular function. Henning RJ; Khalil IR; Levy MN Am J Physiol; 1990 May; 258(5 Pt 2):H1470-5. PubMed ID: 2337181 [TBL] [Abstract][Full Text] [Related]
14. Synergistic hypotensive effect of vasoactive intestinal polypeptide and alpha-blockade with phentolamine. Evidence for vasoactive intestinal peptide alpha-adrenoceptor coupling in the cardiovascular system of newborn dogs. Mas MS; Adams DJ; Gelband H Circ Res; 1990 Oct; 67(4):986-92. PubMed ID: 2170054 [TBL] [Abstract][Full Text] [Related]
15. Effect of intracavernous simultaneous injection of acetylcholine and vasoactive intestinal polypeptide on canine penile erection. Takahashi Y; Aboseif SR; Benard F; Stief CG; Lue TF; Tanagho EA J Urol; 1992 Aug; 148(2 Pt 1):446-8. PubMed ID: 1635155 [TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the anesthetized dog. Hill MR; Wallick DW; Mongeon LR; Martin PJ; Levy MN Am J Physiol; 1995 Oct; 269(4 Pt 2):H1467-72. PubMed ID: 7485582 [TBL] [Abstract][Full Text] [Related]
17. Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside. Vatner SF; Higgins CB; Patrick T; Franklin D; Braunwald E J Clin Invest; 1971 Dec; 50(12):2585-95. PubMed ID: 5129310 [TBL] [Abstract][Full Text] [Related]